Abstract
Background: Spatial cognition, a skill paramount to survival, is impaired in Parkinson’s disease (PD) but has been little researched. Spatial cognition is utilized during motor–cognitive integration, which impacts daily functioning and quality of life in PD. As PD is a unilateral-onset condition, spatial–cognitive and motor–cognitive ability may differ by side of onset. Spatial cognition is suggested to be modulated by the right hemisphere; thus, we hypothesize to observe worse spatial and motor–cognitive performance by people with left-onset PD (LOPD) than right-onset PD (ROPD). Methods: 216 participants with PD were recruited (LOPD = 107; M = 62; mean age = 69.80 ± 8.5). Spatial outcomes were collected via the body position spatial task (BPST), Reverse Corsi Blocks, and visuospatial items of the Montreal Cognitive Assessment (MoCA); motor–cognitive outcomes were collected by a Trails test, a Four Square Step Test (FSST), and a Timed Up and Go test. An independent t-test and the Mann–Whitney U test compared outcome variables between onset groups. Results: No significant differences were found between onset groups. Exploratory subgroup analyses revealed differences. Significantly worse performance by LOPD in single- and dual-task TUG was found within people with bilateral symptoms and postural instability (Hoehn & Yahr stage, >2; LOPD, N = 33; single, p = 0.001; dual, p = 0.021) and worse performance in single-task TUG in people with MoCA < 18 (LOPD, N = 5; single, p = 0.036) and people with freezing of gait (FOGQ, >0; LOPD, N = 14, p = 0.048). Significantly larger DTC by LOPD was found within frequent freezers (FOGQ, >3; LOPD, N = 9; p = 0.003). Conclusions: LOPD may tend to perform worse in motor–cognitive tasks among subgroups of those with more severe symptoms, i.e., those at later stages of disease. These findings may have implications for prognoses of those with LOPD versus ROPD and suggest that those with LOPD may have worse long-term outcomes in spatial cognition and motor–cognitive integration.
Funding Information
  • Patient-Centered Outcomes Research Institute (1099-EU)
  • U.S. Department of Veterans Affairs (5IK2RX000870-06)
  • U.S. Department of Veterans Affairs (1 I01 RX002967)
  • U.S. Department of Veterans Affairs (IK2RX000870)
  • Parkinson's Foundation (PF-0000049408)
  • Parkinson's Foundation (A7-2018-Supplement)
  • Parkinson's Foundation (PF-CGP_19208_DREAM On)
  • Parkinson's Foundation (A-01)
  • National Institute of Neurological Disorders and Stroke (1K23NS105944-01A1)
  • American Parkinson’s Disease Association Center for Advanced Research at Emory University
  • National Institute of Child Health and Human Development (F32HD108927)
  • National Institute on Aging of the National Institutes of Health (R01AG062691)
  • Emory University Goizueta Alzheimer’s Disease Research Center CEP Innovation Accelerator Seed Grant
  • Office of the Emory University Senior Vice President of Research Intersection Fund

This publication has 69 references indexed in Scilit: